Understanding the factors affecting hospitalization costs in laparoscopic hiatal hernia repair can optimize surgical strategies and patient management. Material costs accounted for over 58% of total hospitalization expenses annually. Using absorbable sutures instead of tackers significantly reduced costs across all patient cost percentiles (up to $11,671 savings). Longer hospital stays raised costs and ICU use […]
Category: Upper Gastrointestinal Tract
Myotomy Methods Equal for Type III Achalasia Patients
Both per oral endoscopic myotomy (POEM) and laparoscopic Heller myotomy (LHM) deliver similar outcomes for treating Type III achalasia, suggesting flexibility in surgical approach. Success rates post-procedure were nearly identical: 88% for POEM (14 of 16) vs. 87% for LHM (26 of 30), with p=0.94. Re-intervention rates were also similar: 25% for POEM and 16.7% […]
Intrathoracic Side-Overlap Technique Improves Recovery in Esophagectomy
Side-overlap esophagogastrostomy offers significant benefits over circular stapled techniques for Siewert type I/II adenocarcinoma. Postoperative pain scores on day 1 and 2 were significantly lower in the side-overlap group (3.49 vs. 4.04 and 2.73 vs. 3.06, respectively). Severe gastroesophageal reflux occurred in just 14.5% of the side-overlap group versus 34.0% with circular stapling. Dysphagia symptoms […]
Effective Therapies Cut Esophageal Stricture After ESD
Oral hydrocortisone sodium succinate with aluminum phosphate gel significantly reduces postoperative esophageal stricture after endoscopic submucosal dissection (ESD). This combination therapy lowers stricture risk by 92.5% compared to standard care (relative risk = 0.075). Using polyglycolic acid sheets with fibrin glue minimizes the need for endoscopic balloon dilatation, reducing sessions by an average of 6.4. […]
Gastric partitioning cuts complications in gastric outlet obstruction
Stomach-partitioning gastrojejunostomy (SPGJ) outperforms conventional gastrojejunostomy (CGJ) in managing gastric outlet obstruction (GOO). SPGJ reduces delayed gastric emptying by 76% (relative risk = 0.24). Major postoperative complications drop by 74% (relative risk = 0.26). SPGJ offers a strong alternative to CGJ with similar survival rates and length of stay. No significant difference in reintervention rates […]
New Nomogram Predicts Spontaneous Closure in Duodenal Fistulas
A newly developed nomogram predicts spontaneous closure in septic patients with external duodenal fistulas post-infection control, critical for surgery decisions. Spontaneous closure rates after infection control were 53.2% in the development cohort and 57% in validation. Six key factors were identified: time to infection control, infection extent, emergency surgery, fistula size, duodenal decompression, and albumin […]
Endoscopic Dissection Transforms Early Upper GI Carcinoma Care
Endoscopic Submucosal Dissection (ESD) provides an advanced local treatment option for early upper gastrointestinal carcinomas, enabling complete tumor removal and improved patient outcomes. ESD allows for en bloc resection of early GI neoplasia, aiding in precise pathology and risk assessment. Key candidates for ESD include high-grade intraepithelial neoplasia and superficial early carcinomas without visible deep […]
Gastric Distension Index Predicts Stasis After Gastrectomy
A new index predicts gastric stasis post-gastrectomy, crucial for improving surgical outcomes. In a study of 203 patients, the Hiki Index showed 85.7% sensitivity and 76.7% specificity for stasis-related interventions. Age under 75, female sex, and pylorus-preserving gastrectomy raise risk for gastric distension. Implementing the Hiki Index can lead to timely interventions and better postoperative […]
Totally laparoscopic pylorus-preserving gastrectomy is safe for early gastric cancer.
Patients undergoing pylorus-preserving surgery had shorter operative times (226 vs. 272 minutes) and shorter hospital stays (9.2 vs. 10.5 days). Higher risk of delayed gastric emptying was noted (12.5% vs. 1.6%). Patients in the pylorus-preserving group showed improved nutritional status and quality of life. Consider pylorus-preserving approaches for selected early-stage cases to enhance postoperative outcomes, […]
Flot Outperforms Cross in Esophageal Adenocarcinoma Survival
Flot chemotherapy shows a clear survival advantage over the Cross protocol for esophageal adenocarcinoma, impacting treatment choices. Esopec trial: median overall survival (OS) for Flot at 66 months vs. 37 months for Cross (HR: 0.70, p=0.01). Real-world data: Cross cohort median OS at 33.7 months, with a higher pathological complete response (PCR) of 20.5% versus […]